Arq. Bras. Cardiol. 2023; 120(10): e20230268
Mitral Valve Endocarditis – An Unusual Culprit in a Cancer Patient
Fabiana Duarte
, Carina Machado, Luis Oliveira, Duarte Machado, Raquel Dourado
Introduction
Cancer patients are prone to infective endocarditis (IE), associated with specific causative agents, leading to poorer outcomes. The prevalence of IE in cancer patients ranges from 5.6% to 18%, with a reported 1-year mortality rate of nearly 30%. – Risk factors, such as a suppressed immune system, intravascular catheter use, and hypercoagulability, predispose malignancy patients to IE. ,
Clinical evolution is unfavorable due to high mortality rates related to antibiotic resistance, underlying medical conditions, lack of performed surgical interventions, and antitumoral therapy regimen discontinuation. –
[…]
Keywords: Drug Therapy; Echocardiography; Endocarditis
741
